Since ALB <35 g/L and dNLR >3 were closely associated with unfavorable prognosis in NSCLC patients treated with ICIs, we constructed a new prognostic index, ICPI, based on the two risk factors. This evidence concerns the gene ALB and non-small cell lung carcinoma.